Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Riluzole, mecasermin cost effective in ALS?

    • 10 Accesses

    This is a preview of subscription content, log in to check access.

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Riluzole, mecasermin cost effective in ALS?. Pharmacoecon. Outcomes News 367, 5 (2002). https://doi.org/10.1007/BF03279192

    Download citation

    Keywords

    • Public Health
    • Health Outcome
    • Amyotrophic Lateral Sclerosis
    • Cost Effectiveness
    • Health Economic